Taysha Gene Therapies, Inc. financial data

Symbol
TSHA on Nasdaq
Location
3000 Pegasus Park Drive, Suite 1430, Dallas, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 855 % +91.5%
Debt-to-equity 59.6 % -48.8%
Return On Equity -67.3 % -141%
Return On Assets -42.1 % -227%
Operating Margin -1.62K % -82.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 274M shares +33.7%
Common Stock, Shares, Outstanding 274M shares +33.7%
Entity Public Float 371M USD +1119%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 353M shares +31.9%
Weighted Average Number of Shares Outstanding, Diluted 353M shares +31.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 6.31M USD -36.4%
Research and Development Expense 76.8M USD +21.2%
General and Administrative Expense 31.7M USD +9.03%
Operating Income (Loss) -102M USD -16.4%
Nonoperating Income (Expense) 2.2M USD -96.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -99.9M USD -339%
Earnings Per Share, Basic 0 USD/shares -197%
Earnings Per Share, Diluted 0 USD/shares -197%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 297M USD +88.6%
Other Assets, Current 456K USD -1.94%
Assets, Current 300M USD +85.7%
Property, Plant and Equipment, Net 6.81M USD -10.6%
Operating Lease, Right-of-Use Asset 7.46M USD -14%
Other Assets, Noncurrent 184K USD -16.4%
Assets 317M USD +75.7%
Accounts Payable, Current 5.44M USD +10.3%
Employee-related Liabilities, Current 5.35M USD +37.3%
Liabilities, Current 28.6M USD -2.4%
Operating Lease, Liability, Noncurrent 16.5M USD -7.01%
Other Liabilities, Noncurrent 1.58M USD +15.6%
Liabilities 97.6M USD +6.72%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.14M USD +50.9%
Retained Earnings (Accumulated Deficit) -683M USD -17.1%
Stockholders' Equity Attributable to Parent 219M USD +147%
Liabilities and Equity 317M USD +75.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22M USD -11.2%
Net Cash Provided by (Used in) Financing Activities -52K USD -136%
Net Cash Provided by (Used in) Investing Activities -371K USD -165%
Common Stock, Shares Authorized 700M shares +75%
Common Stock, Shares, Issued 274M shares +33.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -22.4M USD -12.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.29M USD -2.63%
Deferred Tax Assets, Valuation Allowance 114M USD +24%
Deferred Tax Assets, Gross 116M USD +23.1%
Operating Lease, Liability 17.8M USD -7.48%
Depreciation 1.1M USD -12.8%
Payments to Acquire Property, Plant, and Equipment 140K USD -96.4%
Lessee, Operating Lease, Liability, to be Paid 25.5M USD -12.2%
Property, Plant and Equipment, Gross 11.2M USD -2.92%
Operating Lease, Liability, Current 1.25M USD -13.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.58M USD +3.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.49M USD -14.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.79M USD -21.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.67M USD +3.73%
Deferred Tax Assets, Operating Loss Carryforwards 57M USD +20.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.78M USD +3.97%
Operating Lease, Payments 2.74M USD +296%
Additional Paid in Capital 904M USD +33.9%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 13M USD +9.53%
Interest Expense 2.24M USD -56.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%